Royalty Pharma plc (RPRX) Adds to IPO Gains
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Join SI Premium – FREE
Yesterday's IPO for Royalty Pharma plc (NASDAQ: RPRX) adds to gains. Shares are up 6.5% to $47.38.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump, Asked If Open To Direct Talks With Iran, Says Yes
- Dayone Data Centers Files For US IPO
- Option Care Health Surges 22% Postmarket After FT Report
Create E-mail Alert Related Categories
IPOs, Momentum Movers, Trader TalkRelated Entities
IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
